Search research articles
Contact Us
Filters
Showing results (111-120 of 347) with videos related to
Page
of 35
Sort By:
Oncotarget
|
May 5, 2016
Genetic alteration profiling of patients with resected squamous cell lung carcinomas
Dan Tao, Xiaohong Han, Ningning Zhang, et al.
Cancer Communications (London, England)
|
May 31, 2018
Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial
Yan Qin, Yuqin Song, Zhixiang Shen, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2022
Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients
Yu Feng, Le Tang, Hongyu Wang, et al.
Thoracic Cancer
|
August 8, 2023
Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysis
Yu Feng, Yunxia Tao, Haizhu Chen, et al.
BMC Medicine
|
November 24, 2022
Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study
Puyuan Xing, Qian Zhao, Li Zhang, et al.
Therapeutic Advances in Medical Oncology
|
September 25, 2020
Nimotuzumab plus platinum-based chemotherapy <i>versus</i> platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
Yunshu Zhu, Sheng Yang, Shengyu Zhou, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
September 17, 2013
[A retrospective study of the efficacy and toxicity of irinotecan in combination with nedaplatin versus irinotecan in combination with cisplatin as salvage treatment in refractory or relapsed small cell lung cancer]
Shufei Yu, Yan Wang, Xingsheng Hu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 15, 2026
DSG2+ Cancer Stem Cells Co-Located With FAP+ Myofibroblasts in the Tumor Boundary That Determines the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer
Guangyu Fan, Le Tang, Tongji Xie, et al.
International Journal of Hematology
|
December 11, 2008
Study of conditioning regimens with or without high-dose radiotherapy before autologous stem cell transplantation for treating aggressive lymphoma
Yi Niu, Yuankai Shi, Shengyu Zhou, et al.
Cancer Pathogenesis and Therapy
|
September 9, 2025
Economic burden and health-related quality of life in Chinese patients with mycosis fungoides and Sézary syndrome
Yuankai Shi, Jianfang Sun, Huiping Sun, et al.
Page
of 35
Search research articles
Search
Showing results (111-120 of 347) with videos related to
Sort By:
Page
of 35
Oncotarget
|
May 5, 2016
Genetic alteration profiling of patients with resected squamous cell lung carcinomas
Dan Tao, Xiaohong Han, Ningning Zhang, et al.
Cancer Communications (London, England)
|
May 31, 2018
Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial
Yan Qin, Yuqin Song, Zhixiang Shen, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2022
Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients
Yu Feng, Le Tang, Hongyu Wang, et al.
Thoracic Cancer
|
August 8, 2023
Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysis
Yu Feng, Yunxia Tao, Haizhu Chen, et al.
BMC Medicine
|
November 24, 2022
Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study
Puyuan Xing, Qian Zhao, Li Zhang, et al.
Therapeutic Advances in Medical Oncology
|
September 25, 2020
Nimotuzumab plus platinum-based chemotherapy <i>versus</i> platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
Yunshu Zhu, Sheng Yang, Shengyu Zhou, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
September 17, 2013
[A retrospective study of the efficacy and toxicity of irinotecan in combination with nedaplatin versus irinotecan in combination with cisplatin as salvage treatment in refractory or relapsed small cell lung cancer]
Shufei Yu, Yan Wang, Xingsheng Hu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 15, 2026
DSG2+ Cancer Stem Cells Co-Located With FAP+ Myofibroblasts in the Tumor Boundary That Determines the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer
Guangyu Fan, Le Tang, Tongji Xie, et al.
International Journal of Hematology
|
December 11, 2008
Study of conditioning regimens with or without high-dose radiotherapy before autologous stem cell transplantation for treating aggressive lymphoma
Yi Niu, Yuankai Shi, Shengyu Zhou, et al.
Cancer Pathogenesis and Therapy
|
September 9, 2025
Economic burden and health-related quality of life in Chinese patients with mycosis fungoides and Sézary syndrome
Yuankai Shi, Jianfang Sun, Huiping Sun, et al.
Page
of 35